Skip to main content

Sepio Capital, LP

Position in NVO — Novo Nordisk A S

CIK 1751412 Salt Lake City, UT

Position in NVO

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$1,730,394
+$428,489 QoQ
Shares Held
36,095
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#409
of 1,348 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Sepio Capital, LP holds $43,754,387 across 7 Drug Manufacturers - General names. NVO ranks #4 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
36,095 $1,730,394

All Filings in NVO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,730,394 36,095
2026-03-31 $1,301,905 35,426
2025-12-31 $1,654,007 32,508
2025-09-30 $1,863,742 33,587
2025-06-30 $1,890,526 27,391
2025-03-31 $1,899,808 27,359
2024-12-31 $1,712,142 19,904
2024-09-30 $2,386,400 20,042
2024-06-30 $2,882,777 20,196
2024-03-31 $2,603,181 20,274
2023-12-31 $2,301,141 22,244
2023-09-30 $2,337,612 25,705
2023-06-30 $2,054,108 12,693
2023-03-31 $2,100,807 13,201
2022-12-31 $2,060,957 15,228
2022-09-30 $1,747,709 17,542
2022-06-30 $2,032,928 18,244
2022-03-31 $2,092,848 18,846
2021-12-31 $2,260,048 20,179
2021-09-30 $1,932,969 20,133
2021-03-31 $1,505,758 22,334